Terms: = Skin cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
38 results:
1. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
Chen S; McMiller TL; Soni A; Succaria F; Sidhom JW; Cappelli LC; Casciola-Rosen LA; Morales IR; Sankaran P; Berger AE; Deutsch JS; Zhu QC; Anders RA; Hooper JE; Pardoll DM; Lipson EJ; Taube JM; Topalian SL
J Transl Med; 2024 Mar; 22(1):241. PubMed ID: 38443917
[TBL] [Abstract] [Full Text] [Related]
2. Effects of extracellular vesicles from adipose-derived stem cells on human keloid fibroblasts via the socs1/JAK2/STAT3 pathway.
Ruan H; Wang J; Shi H; Luan W
J Cosmet Dermatol; 2024 Apr; 23(4):1404-1416. PubMed ID: 38288516
[TBL] [Abstract] [Full Text] [Related]
3. Anaplastic Large Cell Transformation of Mycosis Fungoides: Case Report and Review of the Literature.
Flerova E; Alpdogan O; Bhatti S; Nikbakht N; Wang ZX; Gong JZ
Am J Dermatopathol; 2023 Sep; 45(9):e74-e82. PubMed ID: 37625813
[TBL] [Abstract] [Full Text] [Related]
4. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
5. [Newly diagnosed melanoma diagnosed on the basis of cutaneous side effects from COVID-19 vaccine].
Eskandarani HA; Gjørup C; Nørgaard P; Hölmich LR
Ugeskr Laeger; 2022 May; 184(22):. PubMed ID: 35656609
[TBL] [Abstract] [Full Text] [Related]
6. Open and Closed Approaches to skin Closure After Nonelective Open Colorectal Operations.
Turcotte JJ; Allen RS; Klune JR; Feather CB
Am Surg; 2023 Jun; 89(6):2520-2528. PubMed ID: 35580356
[TBL] [Abstract] [Full Text] [Related]
7. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K
J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657
[TBL] [Abstract] [Full Text] [Related]
8. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract] [Full Text] [Related]
9. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy.
Wei J; Long L; Zheng W; Dhungana Y; Lim SA; Guy C; Wang Y; Wang YD; Qian C; Xu B; Kc A; Saravia J; Huang H; Yu J; Doench JG; Geiger TL; Chi H
Nature; 2019 Dec; 576(7787):471-476. PubMed ID: 31827283
[TBL] [Abstract] [Full Text] [Related]
10. Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and socs1 in mycosis fungoides.
Bastidas Torres AN; Cats D; Mei H; Szuhai K; Willemze R; Vermeer MH; Tensen CP
Genes Chromosomes Cancer; 2018 Dec; 57(12):653-664. PubMed ID: 30144205
[TBL] [Abstract] [Full Text] [Related]
11. Effect of socs1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
Yu SJ; Long ZW
Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
[TBL] [Abstract] [Full Text] [Related]
12. SOCS3 inhibits the pathological effects of IL-22 in non-melanoma skin tumor-derived keratinocytes.
Madonna S; Scarponi C; Morelli M; Sestito R; Scognamiglio PL; Marasco D; Albanesi C
Oncotarget; 2017 Apr; 8(15):24652-24667. PubMed ID: 28445952
[TBL] [Abstract] [Full Text] [Related]
13. Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
Tagami-Nagata N; Serada S; Fujimoto M; Tanemura A; Nakatsuka R; Ohkawara T; Murota H; Kishimoto T; Katayama I; Naka T
Exp Dermatol; 2015 Nov; 24(11):864-71. PubMed ID: 26173926
[TBL] [Abstract] [Full Text] [Related]
14. Suspicious macroscopic features of small malignant colorectal polyps.
Bugajski M; Kaminski MF; Orlowska J; Mroz A; Pachlewski J; Rupinski M; Zagorowicz E; Rawa T; Regula J
Scand J Gastroenterol; 2015; 50(10):1261-7. PubMed ID: 25865832
[TBL] [Abstract] [Full Text] [Related]
15. Effects of suppressor of cytokine signaling 1 silencing on human melanoma cell proliferation and interferon-γ sensitivity.
Xu Y; Wang W; Gou A; Li H; Tian Y; Yao M; Yang R
Mol Med Rep; 2015 Jan; 11(1):583-8. PubMed ID: 25322862
[TBL] [Abstract] [Full Text] [Related]
16. A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.
Ferrara G; Pancione M; Votino C; Quaglino P; Tomasini C; Santucci M; Pimpinelli N; Cusano F; Sabatino L; Colantuoni V
Br J Dermatol; 2014 Jun; 170(6):1266-75. PubMed ID: 24641245
[TBL] [Abstract] [Full Text] [Related]
17. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of socs1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract] [Full Text] [Related]
18. Atypical melanocytic naevi following melanotan injection.
Reid C; Fitzgerald T; Fabre A; Kirby B
Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
Busse A; Rapion J; Fusi A; Suciu S; Nonnenmacher A; Santinami M; Kruit WH; Testori A; Punt CJ; Dalgleish AG; Spatz A; Eggermont AM; Keilholz U
Cancer Immunol Immunother; 2013 Jul; 62(7):1223-33. PubMed ID: 23624802
[TBL] [Abstract] [Full Text] [Related]
20. Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells.
Parrillas V; Martínez-Muñoz L; Holgado BL; Kumar A; Cascio G; Lucas P; Rodríguez-Frade JM; Malumbres M; Carrera AC; van Wely KH; Mellado M
Cell Mol Life Sci; 2013 Feb; 70(3):545-58. PubMed ID: 23001011
[TBL] [Abstract] [Full Text] [Related]
[Next]
